NRC Health

What they do

NRC Health provides healthcare organizations with consumer and patient insights, experience improvement solutions, and governance support. Its offerings include national market research, patient experience measurement, and strategic engagement services, delivered through a combination of data analytics and advisory services.

Revenue drivers

• Recurring subscription and contract revenue — Core revenue comes from recurring contracts for patient experience measurement, consumer insights, and related SaaS and data services. TRCV was $151.9 million as of Q2 2026, up 11% year-over-year.
• The Governance Institute — A business line delivering governance education, benchmarking, and advisory services to healthcare boards and executives. It reported its strongest bookings in seven years during Q2 2026.
• Product innovations and commercialization — Management cites continued commercialization of new product innovations as a growth driver, noting strong go-to-market execution as a contributor to Q2 2026 performance.

Recent performance

In Q2 2026, revenue was $35.4 million, up 4% year-over-year. GAAP net loss was ($3.3) million, reflecting accelerated stock vesting and cash bonuses, while adjusted net income was $6.9 million and adjusted EBITDA was $9.4 million (27% of revenue). Operating cash flow was $1.4 million, with free cash flow of $0.1 million after a $2.9 million cash payment related to adjustment items. Quarterly revenue has been steady around $34.6–$35.4 million over the last four reported quarters.

Strategy

NRC Health is focused on three connected strengths: delivering continuous consumer and patient insights, building trusted partnerships with healthcare leaders, and enabling actions that improve outcomes. Management emphasizes strong go-to-market execution, commercialization of product innovations, and leveraging The Governance Institute's momentum. The company aims to differentiate through an empathic, human-centered approach to healthcare experience and brand value.

Risks

• Customer concentration in healthcare — Revenue depends on healthcare providers, who face consolidation and budget pressures that could reduce spending on NRC's services.
• High leverage and thin equity — As of June 30, 2026, total liabilities of $129.6 million exceed assets by a wide margin, with long-term debt of $86.0 million and shareholder equity of only $6.5 million, increasing financial risk.
• Execution on transformation — The company is mid-transition under new CEO Trent Green (since June 2025), with pressure to sustain TRCV growth and bookings momentum.
• Cash flow volatility — Operating cash flow fell to $1.4 million in Q2 2026, and free cash flow was near zero after special payments, limiting flexibility for debt service or dividends.

Outlook

Management expects a strong second half of 2026, citing double-digit TRCV growth, a strong pipeline, and the best Governance Institute bookings in seven years. They remain focused on converting TRCV into revenue and improving profitability. The board declared a quarterly dividend of $0.16 per share, payable in October 2026.